Possibilities of Medicamental Treatment for Obstructive Sleep Apnoea in Children
Pediatric pharmacology · 2016
DOI: 10.15690/pf.v13i4.1610 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric pharmacology, 2016. Verfasst von E. N. Latysheva und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
We have conducted a critical analysis of publications regarding the possibilities of medicamental treatment of obstructive sleep apnoea syndrome in children. Based on the examined studies we made a conclusion that intranasal glucocorticosteroids and leukotriene receptor antagonists can be effective in children with light and moderate lesions of this nature. At the same time, for the time being there isn’t enough published data to justify the recommendation of mentioned preparations as an alternative to surgery in children suffering from pulmonary ventilation stoppages. Further studies are required in order to determine the optimal terms of conservative treatment of obstructive sleep apnea in children, to determine the durability of the effect and ascertain the indications and contraindications for different groups of preparations.
Zitieren
APA
Latysheva, E. N., Rusetsky, Y. Y., Malyavina, U. S., & Khramov, P. A. (2016). Possibilities of Medicamental Treatment for Obstructive Sleep Apnoea in Children. Pediatric pharmacology. https://doi.org/10.15690/pf.v13i4.1610
Vancouver
Latysheva EN, Rusetsky YY, Malyavina US, Khramov PA. Possibilities of Medicamental Treatment for Obstructive Sleep Apnoea in Children. Pediatric pharmacology. 2016. doi:10.15690/pf.v13i4.1610
BibTeX
@article{Latysheva2016,
author = {Latysheva, E. N. and Rusetsky, Yu. Yu. and Malyavina, U. S. and Khramov, P. A.},
title = {Possibilities of Medicamental Treatment for Obstructive Sleep Apnoea in Children},
journal = {Pediatric pharmacology},
year = {2016},
doi = {10.15690/pf.v13i4.1610}
}
EUVIMED